Plexin signalling in melanocyte biology and melanoma progression

黑色素细胞生物学和黑色素瘤进展中的 Plexin 信号传导

基本信息

  • 批准号:
    7561338
  • 负责人:
  • 金额:
    $ 31.78万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-01 至 2014-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Human melanocytes are neural crest derived cells that perform a unique function in the skin. While they are a minority of the population of the epidermis, they are responsible for the majority of photoprotection of the skin from ultraviolet radiation (UVR) through the production and transfer of melanin to keratinocytes [1]. Melanocytes, or their stem cells, are also progenitor cells for the most deadly of skin cancers, melanoma, which arises as a step wise progression from benign, to minimally invasive, to metastatic tumor [2]. Paracrine factors, produced primarily by keratinocytes, but also by fibroblasts, control multiple melanocyte functions, including dendricity, migration, growth and pigmentation, and also regulate normal homeostasis of melanocytes in the skin. Disordered of these growth factors, their receptors, or signaling pathways, are implicated in melanoma progression, as well as in disordered pigmentation [3]. Therefore, discovery of new or novel paracrine factors, and defining receptors and signaling pathways stimulated by these factors, are important to understanding melanocyte regulation in the skin, and melanoma tumor progression. Semaphorins are a large family of proteins that were originally identified in the nervous system, and are critical regulators of axon guidance. During the last 5 years, numerous reports show that semaphorins and their receptors (Plexins and Neuropilins) are widely distributed and regulate multiple biologic processes, including cell adhesion and migration, neurite extension, immune function, organogenesis, and tumor progression. Our published and preliminary data show a previously unrecognized role for semaphorins in human melanocyte function. Semaphorin 4D and semaphorin 7A regulate multiple cellular processes in other cell types, including neurite outgrowth and retraction, tumor progression and immune modulation [4]. We are the first to show that semaphorin 4D (Sema4D) and semaphorin 7A (Sema7A) control melanocyte attachment, spreading and dendricity, which are critically important for normal skin pigmentation. Further, our data suggest a potential role for Sema4D and Sema7A in melanoma progression, because their cognate receptors (Plexin B1 and Plexin C1 respectively) are either reduced or absent in melanoma. Finally, our preliminary data indicate a novel role for Sema4D in downregulation of c-Met receptor activation, a receptor critically important for melanocyte cell growth, migration, differentiation, and melanoma progression. We hypothesize that Sema4D and Sema7A regulate melanocyte migration and dendrite formation through stimulation of intracellular signaling pathways that include the GTP binding proteins Ras, Rho, Rac, integrins and LIM kinase- cofilin pathways. We predict that effects of Sema7A are mediated by a balance between 1- integrin and cofilin activation. We predict that effects of Sema4D are mediated by a balance between c-Met receptor inhibition and Plexin B1 activation. Finally, we predict that loss of Plexin B1 and Plexin C1 expression contribute to melanoma progression through enhanced melanoma cell growth, migration, and survival due to loss of c-Met receptor inhibition and coflin activation, respectively. PUBLIC HEALTH RELEVANCE. Identification of new growth factors that regulate human melanocyte function is important for understanding pigmentation of the skin, and in the transformation of benign melanocytes to malignant melanoma. We have identified two proteins, Semaphorin 4D and Semaphorin 7A, which stimulate human melanocyte function through the receptors Plexin B1 and Plexin C1 respectively. Further, we show that both of these receptors are reduced or absent in melanoma cell lines, and, in the case of Plexin C1, in melanoma in vivo. The goal of this project is to define how Semaphorins signal through Plexin receptors, and to understand the mechanisms by which loss of Plexin receptor expression contributes to melanoma metastasis.
描述(由申请人提供):人黑素细胞是神经嵴衍生的细胞,在皮肤中执行独特的功能。虽然它们是表皮的少数群体,但它们通过产生黑色素并将其转移到角质形成细胞来负责皮肤免受紫外线辐射(UVR)的大部分光保护[1]。黑素细胞或其干细胞也是最致命的皮肤癌黑色素瘤的祖细胞,其作为从良性到微创再到转移性肿瘤的逐步进展而出现[2]。旁分泌因子主要由角质形成细胞产生,但也由成纤维细胞产生,控制多种黑素细胞功能,包括树突、迁移、生长和色素沉着,并且还调节皮肤中黑素细胞的正常稳态。这些生长因子、其受体或信号传导途径的紊乱与黑色素瘤进展以及色素沉着紊乱有关[3]。因此,发现新的或新的旁分泌因子,并确定受体和信号通路刺激这些因素,是重要的了解黑素细胞在皮肤中的调节,黑色素瘤肿瘤的进展。脑信号蛋白是最初在神经系统中鉴定的蛋白质的大家族,并且是轴突引导的关键调节剂。在过去的5年中,大量的研究表明,脑信号蛋白及其受体(丛蛋白和神经纤毛蛋白)广泛分布,并调节多种生物过程,包括细胞粘附和迁移,神经突起延伸,免疫功能,器官发生和肿瘤进展。我们发表的和初步的数据显示了以前未被认识到的作用,脑信号蛋白在人类黑素细胞的功能。脑信号蛋白4D和脑信号蛋白7A调节其他细胞类型中的多种细胞过程,包括神经突生长和收缩、肿瘤进展和免疫调节[4]。我们是第一个表明,semaphorin 4D(Sema 4D)和semaphorin 7A(Sema 7A)控制黑素细胞的附着,扩散和dendricity,这是至关重要的正常皮肤色素沉着。此外,我们的数据表明Sema 4D和Sema 7A在黑色素瘤进展中的潜在作用,因为它们的同源受体(分别为丛蛋白B1和丛蛋白C1)在黑色素瘤中减少或缺失。最后,我们的初步数据表明,Sema 4D在下调c-Met受体活化方面具有新的作用,c-Met受体活化是黑素细胞生长、迁移、分化和黑色素瘤进展的关键重要受体。我们假设Sema 4D和Sema 7A通过刺激包括GTP结合蛋白Ras、Rho、Rac、整联蛋白和LIM激酶- cofilin途径的细胞内信号传导途径来调节黑素细胞迁移和树突形成。我们预测Sema 7A的作用是由1-整合素和cofilin激活之间的平衡介导的。我们预测Sema 4D的作用是由c-Met受体抑制和丛蛋白B1激活之间的平衡介导的。最后,我们预测,丛蛋白B1和丛蛋白C1表达的损失有助于通过增强黑色素瘤细胞的生长,迁移和生存,由于c-Met受体抑制和coflin激活的损失,分别黑色素瘤进展。 公共卫生相关性。鉴定调节人类黑素细胞功能的新的生长因子对于理解皮肤色素沉着和良性黑素细胞向恶性黑色素瘤的转化是重要的。我们已经鉴定了两种蛋白质,Semaphorin 4D和Semaphorin 7A,它们分别通过受体丛蛋白B1和丛蛋白C1刺激人类黑素细胞功能。此外,我们表明,这两种受体在黑色素瘤细胞系中减少或不存在,并且在丛状蛋白C1的情况下,在体内黑色素瘤中。本项目的目标是确定脑信号蛋白如何通过丛状蛋白受体发出信号,并了解丛状蛋白受体表达缺失导致黑色素瘤转移的机制。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GLYNIS A SCOTT其他文献

GLYNIS A SCOTT的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GLYNIS A SCOTT', 18)}}的其他基金

Plexin signalling in melanocyte biology and melanoma progression
黑色素细胞生物学和黑色素瘤进展中的 Plexin 信号传导
  • 批准号:
    8291374
  • 财政年份:
    2009
  • 资助金额:
    $ 31.78万
  • 项目类别:
Plexin signalling in melanocyte biology and melanoma progression
黑色素细胞生物学和黑色素瘤进展中的 Plexin 信号传导
  • 批准号:
    8505397
  • 财政年份:
    2009
  • 资助金额:
    $ 31.78万
  • 项目类别:
Plexin signalling in melanocyte biology and melanoma progression
黑色素细胞生物学和黑色素瘤进展中的 Plexin 信号传导
  • 批准号:
    8090344
  • 财政年份:
    2009
  • 资助金额:
    $ 31.78万
  • 项目类别:
MECHANISMS OF DENDRITE FORMATION & MELANOSOME TRANSFER
枝晶形成机制
  • 批准号:
    6171137
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:
MECHANISMS OF DENDRITE FORMATION & MELANOSOME TRANSFER
枝晶形成机制
  • 批准号:
    6651111
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:
Role of Prostaglandins & Phospholipase A in melanocytes
前列腺素的作用
  • 批准号:
    7278690
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:
MECHANISMS OF DENDRITE FORMATION & MELANOSOME TRANSFER
枝晶形成机制
  • 批准号:
    6375135
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:
MECHANISMS OF DENDRITE FORMATION & MELANOSOME TRANSFER
枝晶形成机制
  • 批准号:
    6045352
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:
MECHANISMS OF DENDRITE FORMATION & MELANOSOME TRANSFER
枝晶形成机制
  • 批准号:
    6534452
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:
Role of Prostaglandins & Phospholipase A in melanocytes
前列腺素的作用
  • 批准号:
    7482353
  • 财政年份:
    1999
  • 资助金额:
    $ 31.78万
  • 项目类别:

相似海外基金

Genome analysis-based prediction model development for response to stereotactic radiosurgery in benign brain tumors
基于基因组分析的预测模型开发,用于良性脑肿瘤立体定向放射外科治疗的反应
  • 批准号:
    23K08495
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis
高风险良性乳腺诊断女性的临床乳腺癌风险预测模型
  • 批准号:
    10719777
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
Environmentally Benign Precise Transformations of Alkenes by Chiral Chalcogenide Catalysts
手性硫属化物催化剂对环境无害的烯烃精确转化
  • 批准号:
    22KJ2498
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Learners to LeAders in benign Urology, benign Nephrology, and non-Cancer Hematology
良性泌尿外科、良性肾脏病学和非癌症血液学领域的学习者和领导者
  • 批准号:
    10726042
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
The role of estrogen receptor alpha in prostatic fibrosis contributing to benign prostatic hyperplasia
雌激素受体α在导致良性前列腺增生的前列腺纤维化中的作用
  • 批准号:
    10607151
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
Development of a medical device to resolve benign esophageal stricture by heating and traction
开发通过加热和牵引解决良性食管狭窄的医疗设备
  • 批准号:
    23H03765
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Development of benign/malignant differentiation method for thyroid follicular tumor using organoids
利用类器官开发甲状腺滤泡性肿瘤良恶性鉴别方法
  • 批准号:
    23K08075
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of p53 Engagement and Action at the Benign-to-Malignant Transition in Sporadic Tumorigenesis
p53在散发性肿瘤发生良性向恶性转变中的参与和作用机制
  • 批准号:
    10720034
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
I-Corps: Mitigating Multidrug Resistant Bacterial Infections with Biocompatible and Environmentally Benign Nanoantibiotics
I-Corps:利用生物相容性且对环境无害的纳米抗生素减轻多重耐药细菌感染
  • 批准号:
    2306943
  • 财政年份:
    2023
  • 资助金额:
    $ 31.78万
  • 项目类别:
    Standard Grant
Towards Achieving Zero Emissions through the use of an Environmentally Benign Non-Regenerable Solvent to Capture CO2 from Large Point Source Emitters for Direct Permanent Storage in Geological Formation or Usage in Accelerated Curing of Ready-mix Con
通过使用环境友好的不可再生溶剂从大型点源排放器捕获二氧化碳,直接永久储存在地质构造中或用于预拌混凝土的加速固化,从而实现零排放
  • 批准号:
    RGPIN-2022-03431
  • 财政年份:
    2022
  • 资助金额:
    $ 31.78万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了